Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing
- 22 July 2024
- journal article
- review article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 277 (Pt 1) , 134012
Abstract
No abstract availableKeywords
This publication has 395 references indexed in Scilit:
- COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022JAMA Internal Medicine, 2022
- Durability of Heterologous and Homologous COVID-19 Vaccine BoostsJAMA Network Open, 2022
- Nucleocapsid protein of SARS‐CoV‐2 is a potential target for developing new generation of vaccineJournal of Clinical Laboratory Analysis, 2022
- Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021JAMA, 2022
- Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease SeverityJAMA, 2021
- Considerations for Size, Surface Charge, Polymer Degradation, Co‐Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious DiseasesAdvanced NanoBiomed Research, 2020
- In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE‐2 receptor homologs and human TLRsJournal of Medical Virology, 2020
- Association Between Estimated Cumulative Vaccine Antigen Exposure Through the First 23 Months of Life and Non–Vaccine-Targeted Infections From 24 Through 47 Months of AgeJAMA, 2018
- Improved adjuvanting of seasonal influenza vaccines: Preclinical studies of MVA‐NP+M1 coadministration with inactivated influenza vaccineEuropean Journal of Immunology, 2013
- Immunological MemoryJAMA, 2005